Plasma Exchange and Glucocorticoids in ANCA Associated Vasculitis: A Randomised Controlled Trial (PEXIVAS Australia)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/626939

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Vasculitis is a life-threatening disease, and the current treatment for this condition is not satisfactory. This clinical trial aims to determine 1) if plasma exchange can lower mortality and the development of severe kidney failure due to this disease, and 2) if the use of lower doses of corticosteroids can lessen the infectious complications of treatment. This trial is part of a major international effort which will involve a total of 500 patients from Australia, UK, Europe, USA and NZ.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: NHMRC Project Grants

Funding Amount: $635,243.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nephrology and Urology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical trial | glomerulonephritis | glucocorticoids | nephrology | randomised controlled trial | therapeutics | vasculitis

Related Links